01904 488599
TOFACITINIB CITRATE
From £472.00 per (ex VAT)
Tofacitinib citrate, >=98% (HPLC)
| Product Code | PZ0017-25MG |
|---|---|
| Unit of Measure | 1X25MG |
| CAS Number | 540737-29-9 |
| MDL NUMBER | MFCD11616529 |
| EMPIRICAL FORMULA | C16H2N6O |
| Molecular Weight | 504.49 |
| Synonyms | (3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-1-piperidinepropanenitrile citrate salt; 3-[(3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile citrate salt; CP-690550-10; Tasocit |
| Brand | SIGMA-ALDRICH |
Properties
| Property | Value |
|---|---|
| eCl@ss | 32160000 |
| Shipped on ICE | STD |
| UNSPSC Code | 12352200 |
| ADRSuff | 1 |
| CAS Number | 540737-29-9 |
| Storage Temperature | room temp |
| Flash Point | Not applicable |
| GHS Categories | NH |
| GHS Hazard Codes | NH |
| GHS Hazard Statements | NH |
| GHS Pictograms | - |
| GHS Precaution Codes | - |
| GHS Signal Words | - |
| MDL Number | MFCD11616529 |
| Molecular Formula | C16H2N6O |
| Molecular Weight | 504.49 |
| Net Weight | 25 |
| Synonyms | (3R,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-1-piperidinepropanenitrile citrate salt; 3-[(3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile citrate salt; CP-690550-10; Tasocit |
| Tariff Number | 29335995900 |
| Gene Information | human ... JAK1(3716), JAK2(3717), JAK3(3718), TYK2(7297) |
| solubility | DMSO: 5 mg/mL (clear solution; warmed) |
| InChI key | SYIKUFDOYJFGBQ-YLAFAASESA-N |
| InChI | 1S/C16H20N6O.C6H8O7/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16;7-3(8)1-6(13,5(11)12)2-4(9)10/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20);13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)/t11-,13+;/m1./s1 |
| storage temp. | room temp |
| color | white to beige |
| Assay | >=98% (HPLC) |
| originator | Pfizer |
| manufacturer/tradename | Pfizer(R) |
| Quality Level | 100 |
| SMILES string | OC(=O)CC(O)(CC(O)=O)C(O)=O.C[C@@H]1CCN(C[C@@H]1N(C)c2ncnc3[nH]ccc23)C(=O)CC#N |
| form | powder |
Description
Tofacitinib citrate, >=98% (HPLC)